In summary, the present study aimed to explore new therapeutic methods for pulmonary fibrosis, and, in particular, it examined the possible anti-inflammatory, antioxidant and antiapoptotic properties of erythropoietin in the lungs of fibrotic rats induced through the exogenous administration of bleomycin, based on the experimental bleomycin model applied. This evidence concerns the gene EPO and pulmonary fibrosis.